EU Therapeutics Program Hires Biobase to Help Develop Target ID Methods | GenomeWeb
NEW YORK (GenomeWeb News) — A group of European research institutes has hired Biobase to help it develop informatics tools and experimental methods for identifying therapeutic targets, the company said today.
Biobase said it will help develop bioinformatics and cheminformatics for the European Union-commissioned Net2Drug project, which is a consortium of institutes from Europe and Russia that represents interdisciplinary fields including toxicology, systems biology, pharmacology, and cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.